TrueBlue (TBI) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

TBI Stock Forecast


TrueBlue stock forecast is as follows: an average price target of $12.50 (represents a 58.23% upside from TBI’s last price of $7.90) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.

TBI Price Target


The average price target for TrueBlue (TBI) is $12.50 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $13.00 to $12.00. This represents a potential 58.23% upside from TBI's last price of $7.90.

TBI Analyst Ratings


Buy

According to 1 Wall Street analysts, TrueBlue's rating consensus is 'Buy'. The analyst rating breakdown for TBI stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

TrueBlue Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 07, 2024Jeffrey SilberBMO Capital$12.00$7.8952.09%51.90%
May 07, 2024Jeffrey SilberBMO Capital$13.00$10.6322.30%64.56%
May 07, 2024Mark MarconRobert W. Baird$13.00$10.5922.76%64.56%
Row per page
Go to

The latest TrueBlue stock forecast, released on Aug 07, 2024 by Jeffrey Silber from BMO Capital, set a price target of $12.00, which represents a 52.09% increase from the stock price at the time of the forecast ($7.89), and a 51.90% increase from TBI last price ($7.90).

TrueBlue Price Target by Period


1M3M12M
# Anlaysts-13
Avg Price Target-$12.00$12.67
Last Closing Price$7.90$7.90$7.90
Upside/Downside-100.00%51.90%60.38%

In the current month, the average price target of TrueBlue stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to TrueBlue's last price of $7.90. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 07, 2024BMO CapitalOutperformOutperformHold
Jun 17, 2024BMO CapitalOutperformOutperformHold
May 07, 2024BMO CapitalOutperformOutperformHold
May 22, 2023BMO Capital-OutperformUpgrade
Row per page
Go to

TrueBlue's last stock rating was published by BMO Capital on Aug 07, 2024. The company gave TBI a "Outperform" rating, the same as its previous rate.

TrueBlue Financial Forecast


TrueBlue Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue-------------$124.17M$130.49M$465.29M$557.70M$575.72M-$551.51M$621.93M$577.03M$515.96M$458.71M$518.63M$474.53M$358.94M$494.25M$591.04M$636.79M
Avg Forecast$357.65M$361.33M$365.05M$368.81M$406.74M$401.69M$385.73M$369.12M$386.42M$386.07M$414.49M$400.24M$472.53M$488.90M$496.11M$465.30M$560.80M$587.22M$572.77M$531.28M$582.21M$572.12M$506.55M$451.47M$498.08M$454.43M$347.16M$498.87M$601.26M$624.57M
High Forecast$363.60M$367.34M$371.12M$374.95M$413.51M$408.37M$392.15M$375.26M$392.85M$392.49M$421.38M$406.89M$480.39M$493.96M$504.36M$473.03M$570.13M$596.98M$572.77M$536.18M$587.58M$577.40M$511.22M$455.63M$502.67M$458.62M$350.36M$503.47M$606.80M$630.33M
Low Forecast$354.43M$358.08M$361.76M$365.49M$403.08M$398.07M$382.26M$365.79M$382.94M$382.59M$410.75M$396.63M$468.27M$485.78M$491.64M$461.10M$555.75M$581.92M$572.77M$525.34M$575.70M$565.73M$500.89M$446.42M$492.51M$449.35M$343.28M$493.30M$594.54M$617.59M
# Analysts1111----121-131111--2223333323
Surprise %-------------0.25%0.26%1.00%0.99%0.98%-1.04%1.07%1.01%1.02%1.02%1.04%1.04%1.03%0.99%0.98%1.02%

TrueBlue's average Quarter revenue forecast for Dec 23 based on 1 analysts is $472.53M, with a low forecast of $468.27M, and a high forecast of $480.39M. TBI's average Quarter revenue forecast represents a 280.54% increase compared to the company's last Quarter revenue of $124.17M (Sep 23).

TrueBlue EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111----121-131111--2223333323
EBITDA-------------$4.24M$880.00K$468.00K$14.12M$31.57M-$19.28M$29.11M$27.75M$25.96M$13.17M$17.17M$20.36M$-12.45M$9.58M$16.36M$37.94M
Avg Forecast$18.34M$18.53M$18.72M$18.91M$20.85M$20.59M$19.78M$18.92M$19.81M$19.79M$21.25M$21.96M$24.23M$25.07M$25.44M$19.96M$28.75M$31.69M$29.37M$15.78M$14.19M$28.81M$19.83M$76.30M$17.63M$20.82M$-19.21M$-335.35M$19.89M$33.87M
High Forecast$18.64M$18.83M$19.03M$19.22M$21.20M$20.94M$20.11M$19.24M$20.14M$20.12M$21.60M$26.35M$24.63M$25.32M$25.86M$23.95M$29.23M$38.03M$29.37M$18.93M$17.03M$34.57M$23.79M$91.56M$21.16M$24.98M$-15.37M$-268.28M$23.87M$40.64M
Low Forecast$18.17M$18.36M$18.55M$18.74M$20.67M$20.41M$19.60M$18.75M$19.63M$19.62M$21.06M$17.56M$24.01M$24.91M$25.21M$15.97M$28.49M$25.35M$29.37M$12.62M$11.36M$23.05M$15.86M$61.04M$14.11M$16.65M$-23.06M$-402.42M$15.91M$27.09M
Surprise %-------------0.17%0.03%0.02%0.49%1.00%-1.22%2.05%0.96%1.31%0.17%0.97%0.98%0.65%-0.03%0.82%1.12%

1 analysts predict TBI's average Quarter EBITDA for Dec 23 to be $24.23M, with a high of $24.63M and a low of $24.01M. This is 471.64% upper than TrueBlue's previous annual EBITDA (Sep 23) of $4.24M.

TrueBlue Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111----121-131111--2223333323
Net Income-------------$-10.00K$-7.32M$-4.29M$7.04M$20.70M-$10.52M$20.21M$18.64M$15.88M$6.90M$8.03M$8.79M$-8.17M$-150.49M$8.71M$26.68M
Avg Forecast$9.71M$9.10M$6.07M$4.25M$3.34M$2.33M$-809.32K$-4.35M$-3.03M$-4.70M$-1.45M$11.38M$303.49K$7.12M$6.83M$10.35M$13.43M$20.85M$16.64M$8.18M$8.79M$18.95M$11.80M$38.28M$7.40M$8.79M$-12.60M$-304.75M$9.14M$23.09M
High Forecast$9.92M$9.30M$6.20M$4.34M$3.41M$2.38M$-799.83K$-4.30M$-3.00M$-4.65M$-1.43M$13.66M$310.05K$9.29M$6.98M$12.42M$13.72M$25.02M$16.64M$9.82M$10.55M$22.74M$14.16M$45.94M$8.89M$10.55M$-10.08M$-243.80M$10.97M$27.71M
Low Forecast$9.60M$9.00M$6.00M$4.20M$3.30M$2.30M$-826.81K$-4.44M$-3.10M$-4.81M$-1.48M$9.11M$299.93K$4.64M$6.75M$8.28M$13.27M$16.68M$16.64M$6.55M$7.03M$15.16M$9.44M$30.63M$5.92M$7.04M$-15.12M$-365.70M$7.31M$18.47M
Surprise %--------------0.00%-1.07%-0.41%0.52%0.99%-1.29%2.30%0.98%1.35%0.18%1.08%1.00%0.65%0.49%0.95%1.16%

TrueBlue's average Quarter net income forecast for Mar 23 is $10.35M, with a range of $8.28M to $12.42M. TBI's average Quarter net income forecast represents a 46.91% increase compared to the company's last Quarter net income of $7.04M (Dec 22).

TrueBlue SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111----121-131111--2223333323
SG&A-------------$120.72M$121.28M$122.64M$133.73M$124.35M-$120.57M$137.66M$118.75M$110.51M$97.40M$103.63M$90.10M$97.20M$117.38M$133.98M$131.19M
Avg Forecast$81.32M$82.16M$83.00M$83.86M$92.48M$91.34M$87.71M$83.93M$87.86M$87.78M$94.24M$130.49M$107.44M$111.16M$112.81M$118.63M$127.51M$132.80M$130.23M$93.78M$59.87M$120.73M$82.11M$102.65M$95.60M$97.75M$161.16M$113.43M$149.98M$121.14M
High Forecast$82.67M$83.53M$84.39M$85.25M$94.02M$92.85M$89.17M$85.32M$89.32M$89.24M$95.81M$156.59M$109.23M$112.31M$114.68M$142.35M$129.63M$159.36M$130.23M$112.53M$71.84M$144.87M$98.53M$103.60M$114.72M$117.30M$193.39M$114.48M$179.98M$145.37M
Low Forecast$80.59M$81.42M$82.26M$83.10M$91.65M$90.51M$86.92M$83.17M$87.07M$86.99M$93.40M$104.39M$106.47M$110.45M$111.79M$94.90M$126.36M$106.24M$130.23M$75.02M$47.89M$96.58M$65.68M$101.51M$76.48M$78.20M$128.93M$112.16M$119.98M$96.91M
Surprise %-------------1.09%1.08%1.03%1.05%0.94%-1.29%2.30%0.98%1.35%0.95%1.08%0.92%0.60%1.03%0.89%1.08%

TrueBlue's average Quarter SG&A projection for Dec 23 is $107.44M, based on 1 Wall Street analysts, with a range of $106.47M to $109.23M. The forecast indicates a -10.99% fall compared to TBI last annual SG&A of $120.72M (Sep 23).

TrueBlue EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jul 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111----121-131111--2223333323
EPS-------------$-0.00$-0.24$-0.13$0.22$0.64-$0.31$0.58$0.53$0.46$0.20$0.23$0.25$-0.23$-4.04$0.23$0.69
Avg Forecast$0.32$0.30$0.20$0.14$0.11$0.08$-0.03$-0.14$-0.10$-0.15$-0.05$-0.37$0.01$0.23$0.23$-0.11$0.44$0.75$0.54$0.35$0.43$0.60$0.38$-0.04$0.18$0.05$-0.42$0.04$0.41$0.66
High Forecast$0.33$0.31$0.20$0.14$0.11$0.08$-0.03$-0.14$-0.10$-0.15$-0.05$-0.37$0.01$0.31$0.23$-0.11$0.45$0.76$0.54$0.36$0.43$0.60$0.38$-0.04$0.18$0.05$-0.41$0.04$0.41$0.67
Low Forecast$0.32$0.30$0.20$0.14$0.11$0.08$-0.03$-0.15$-0.10$-0.16$-0.05$-0.38$0.01$0.15$0.22$-0.11$0.44$0.74$0.54$0.35$0.42$0.59$0.37$-0.05$0.18$0.05$-0.42$0.04$0.40$0.65
Surprise %--------------0.00%-1.07%1.18%0.50%0.86%-0.87%1.36%0.89%1.23%-4.46%1.29%5.43%0.55%-91.46%0.57%1.04%

According to 1 Wall Street analysts, TrueBlue's projected average Quarter EPS for Mar 23 is $-0.11, with a low estimate of $-0.11 and a high estimate of $-0.11. This represents a -150.00% decrease compared to TBI previous annual EPS of $0.22 (Dec 22).

TrueBlue Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
HSONHudson Global$16.40$42.50159.15%Buy
TBITrueBlue$7.90$12.5058.23%Buy
MANManpowerGroup$73.10$93.4327.81%Buy
KFRCKforce$62.44$71.0013.71%Hold
KELYAKelly Services$21.35$24.0012.41%-
RHIRobert Half$63.86$68.677.53%Hold
KFYKorn Ferry$73.06$75.753.68%Buy
HSIIHeidrick & Struggles$38.07$38.501.13%Hold

TBI Forecast FAQ


Yes, according to 1 Wall Street analysts, TrueBlue (TBI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 100.00% of TBI's total ratings.

TrueBlue (TBI) average price target is $12.5 with a range of $12 to $13, implying a 58.23% from its last price of $7.9. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for TBI stock, the company can go up by 58.23% (from the last price of $7.9 to the average price target of $12.5), up by 64.56% based on the highest stock price target, and up by 51.90% based on the lowest stock price target.

TBI's average twelve months analyst stock price target of $12.5 supports the claim that TrueBlue can reach $12 in the near future.

TrueBlue's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.56B (high $1.59B, low $1.55B), average EBITDA is $80.15M (high $81.48M, low $79.43M), average net income is $505.92K (high $688.92K, low $327.92K), average SG&A $355.45M (high $361.37M, low $352.25M), and average EPS is $0.0167 (high $0.0227, low $0.0108). TBI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.45B (high $1.48B, low $1.44B), average EBITDA is $74.49M (high $75.73M, low $73.82M), average net income is $29.14M (high $29.77M, low $28.79M), average SG&A $330.35M (high $335.84M, low $327.37M), and average EPS is $0.96 (high $0.981, low $0.949).

Based on TrueBlue's last annual report (Dec 2022), the company's revenue was $2.25B, beating the average analysts forecast of $2.25B by 0.09%. Apple's EBITDA was $101.46M, missing the average prediction of $105.58M by -3.91%. The company's net income was $62.27M, beating the average estimation of $59.1M by 5.37%. Apple's SG&A was $500.69M, beating the average forecast of $484.32M by 3.38%. Lastly, the company's EPS was $1.89, missing the average prediction of $2.08 by -9.13%. In terms of the last quarterly report (Sep 2023), TrueBlue's revenue was $124.17M, missing the average analysts' forecast of $488.9M by -74.60%. The company's EBITDA was $4.24M, missing the average prediction of $25.07M by -83.09%. TrueBlue's net income was $-10K, missing the average estimation of $7.12M by -100.14%. The company's SG&A was $120.72M, beating the average forecast of $111.16M by 8.59%. Lastly, the company's EPS was $-0.0003, missing the average prediction of $0.235 by -100.13%